One COVID-19 and Flu Combo Test or Two Separate Tests? Cost per Visit in 2026
Medicare pays the same $74.48 per patient in 2026 whether you run one COVID-19 and flu A/B combo test or separate COVID-19 and flu tests, so the cheaper option is the one with the lower supply cost per visit. A combo test needs one swab, one device and one timed read; separate tests need two of each, so they only come out cheaper when the two tests together cost less than one combo test.
Updated October 2026 with the CMS Clinical Laboratory Fee Schedule for 2026.
Payment is a tie
Medicare pays lab tests from the Clinical Laboratory Fee Schedule, one national limit per code. In 2026 a visually read combo test is billed as one unit of CPT 87812, which pays $74.48. Run as separate tests, the same three answers are billed as 87811 for COVID-19 ($41.38) plus 87804 for influenza, two units when flu A and flu B are reported separately ($16.55 each). That also adds up to $74.48. CMS priced the new code as the sum of the old parts (its 2026 fee schedule update crosswalks 87812 to 87811 plus two units of 87804), so moving to a combo test neither raises nor lowers what Medicare pays for the visit. Commercial and Medicaid rates vary by contract, but the same logic holds wherever a payer prices 87812 at the sum of its parts. For codes, units and the unbundling rule, see our rapid test CPT codes guide.
Same three results, same Medicare payment.
What one visit uses
If payment is equal, the difference is in what each visit consumes. A combo test runs all three targets from a single sample: one anterior nasal swab from both nostrils, one minute in one extraction tube, eight drops on one cassette, and one read between 15 and 20 minutes, per the Instructions for Use for the COVID-19/Flu A&B Antigen Test Pro. Separate tests repeat each of those steps, and each kit's instructions usually call for its own swab (ours says to use only the swab provided in the kit), so the patient is swabbed twice. On the claim, a combo test is one line with one unit; separate tests are two lines, one of them with two units.
Separate tests double every step of the visit.
The break-even rule
Put the two premises together. Payment per visit is the same, and a combo test does the work of two tests with half the handling. So when a clinician wants all three answers, separate tests only cost less if the COVID-19 test and the flu test together cost less than one combo test. At $125 for a box of 25, our combo test is $5.00 per patient. Under Medicare's 2026 rate, that leaves $69.48 per visit after the test itself, before staff time and overhead.
Rule of thumb: add the per-test price of the COVID-19 test you would use to the per-test price of the flu test. If the total is above the combo test's per-test price, the combo test is cheaper per visit, and it also saves a second swab, a second read and a second claim line.
When separate tests still make sense
The comparison above assumes the visit calls for all three answers. That is not always true. When the clinician only needs to know about one virus, a single-target test is the right tool: it costs less than a combo test and is billed under its own code. Payment should never decide which test runs. Payers expect each test to be supported by the documented reason for the visit, and adding a target to raise the claim is the kind of billing that audits look for. The economics in this post only compare tools for the same clinical question: COVID-19, flu A and flu B together, which during respiratory season is common because the symptoms overlap.
Side by side
| Per patient tested for COVID-19, flu A and flu B | One combo test | Separate tests |
|---|---|---|
| CPT codes | 87812, 1 unit | 87811, 1 unit, plus 87804, 2 units |
| Medicare 2026 national limit | $74.48 | $74.48 |
| Swabs per patient | 1 | Usually 2 |
| Devices and timed reads | 1 | 2 |
| Supply cost per patient | One combo test ($5.00 for ours) | COVID-19 test plus flu test |
| QW modifier | When performed under a CLIA Certificate of Waiver | Same, on each waived test |
About the COVID-19/Flu A&B Antigen Test Pro
The COVID-19/Flu A&B Antigen Test Pro is a CLIA waived, 25-test cassette kit (FDA CLIA record CR260386) that detects and differentiates SARS-CoV-2, influenza A and influenza B from one anterior nasal swab, with results read between 15 and 20 minutes. It is billed as 87812, with QW when your site holds a CLIA Certificate of Waiver. Negative results are presumptive, and the Instructions for Use call for confirmation with an FDA-cleared molecular assay when a healthcare provider determines it is appropriate.
Frequently asked questions
Does a COVID and flu combo test pay more than separate tests?
No. Under Medicare's 2026 fee schedule, 87812 pays $74.48, the same as 87811 plus two units of 87804 for the same three results.
Is a combo test cheaper than separate COVID and flu tests?
Per visit, it is cheaper whenever the two separate tests together cost more than one combo test. Our combo test is $5.00 per patient at $125 for a box of 25.
Can I bill 87811 and 87804 for one combo test?
No. A single visually read device that detects SARS-CoV-2 and influenza A and B is one unit of 87812. Billing the split codes for one device is unbundling.
Should I run a combo test on every respiratory patient?
No. Run the test the visit calls for. When only one virus is in question, a single-target test is the better fit.
This article is general information, not billing or legal advice. Confirm codes, units and payment amounts with your payers and the current CMS Clinical Laboratory Fee Schedule.
See pricing and order the COVID-19/Flu A&B Antigen Test Pro. Orders are dispatched from New York, with free shipping on US orders over $300.